Omeros Corp (OMER) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Omeros reported revenue of $0. Net income was -$3.4M, or -$0.05 per diluted share. Operating activities generated -$116.1M of cash, leaving -$116.2M of free cash flow. At fiscal year end, Omeros held $325.6M in total assets against $446.9M in total liabilities, including $9.7M of cash and equivalents.
Open the full interactive Omeros financials → Quarterly statements, key ratios, valuation history and price charts.
Omeros Key Stats
| Share Price | $18.88 |
|---|---|
| Market Cap | $1.69B |
| 52-Week Range | $4.10 – $21.05 |
| Shares Outstanding | 72.1 million (basic, 2026 Q2) |
Omeros Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $73.8M | $0 | $0 | $0 | $0 | $0 |
| Cost of Goods Sold | $902,000 | $173.6M | $163.4M | $164.5M | $169.3M | $122.8M |
| Gross Profit | $72.9M | -$173.6M | -$163.4M | -$164.5M | -$169.3M | -$122.8M |
| Operating Income | -$110.6M | -$173.6M | -$163.4M | -$164.5M | -$169.3M | -$122.8M |
| Pre-Tax Income | -$150.1M | -$191.5M | -$182.0M | -$117.8M | -$154.5M | -$2.8M |
| Income Tax | -$12.0M | $0 | $0 | $0 | $2.3M | $2.0M |
| Net Income | -$138.1M | $194.2M | $47.4M | -$117.8M | -$156.8M | -$3.4M |
| Diluted EPS | -$2.41 | $3.12 | $0.76 | — | — | -$0.05 |
Omeros Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $9.9M | $28.5M |
| Net Income | -$30.9M | $86.5M | $56.1M | $13.2M |
| Diluted EPS | -$0.47 | — | $0.62 | $0.15 |
Omeros Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.5M | $100.8M | $11.0M | $7.1M | $3.4M | $9.7M |
| Current Assets | $151.3M | $247.9M | $443.2M | $217.9M | $134.1M | $215.7M |
| Total Assets | $181.0M | $419.3M | $591.0M | $378.3M | $277.1M | $325.6M |
| Current Liabilities | $36.7M | $51.8M | $136.4M | $53.3M | $79.5M | $78.1M |
| Total Long-Term Debt | $236.3M | $313.5M | $315.3M | $213.2M | $164.9M | $87.9M |
| Total Liabilities | $301.8M | $395.5M | $505.3M | $403.3M | $459.7M | $446.9M |
| Shareholders' Equity | -$120.8M | $23.8M | $85.7M | -$25.0M | -$182.6M | -$121.2M |
Omeros Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$100.1M | -$109.7M | -$86.5M | $74.7M | -$148.8M | -$116.1M |
| Cash From Investing | -$67.0M | $193.7M | -$127.6M | $27.5M | $82.2M | $164.5M |
| Cash From Financing | $174.5M | $6.3M | $124.2M | -$106.1M | $62.9M | -$42.2M |
| Free Cash Flow | -$100.4M | -$110.0M | -$86.6M | $74.3M | -$149.0M | -$116.2M |
Figures from Omeros' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Omeros financials page for every line item.
Omeros Company Profile
| Ticker | OMER |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Seattle, Washington |
| Incorporated in | Washington |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001285819 |
Frequently Asked Questions
What was Omeros' revenue in fiscal 2025?
Omeros (OMER) reported revenue of $0 for fiscal 2025.
What is Omeros' annual revenue history?
Omeros' annual revenue by fiscal year: 2020: $73.8M; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Omeros' net income in fiscal 2025?
Omeros reported net income of -$3.4M for fiscal 2025.
What was Omeros' earnings per share (EPS) in fiscal 2025?
Omeros' diluted EPS was -$0.05 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Omeros generate in fiscal 2025?
Omeros generated -$116.2M of free cash flow in fiscal 2025.
What was Omeros' revenue last quarter?
In its most recent reported quarter (2026 Q2), Omeros reported revenue of $28.5M.
How much debt does Omeros have?
Omeros reported $87.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Omeros are outstanding?
Omeros reported a weighted average of 72.1 million basic shares outstanding in 2026 Q2.
What is Omeros' market cap?
Based on its latest closing price, Omeros (OMER) has a market capitalization of about $1.69B.
When does Omeros' fiscal year end?
Omeros' fiscal year end, as registered with the SEC, is December 31.
Where is Omeros headquartered?
Omeros lists its business address in Seattle, Washington in its SEC filings.